EurekaMag.com logo
+ Site Statistics
References:
53,623,987
Abstracts:
29,492,080
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on LinkedInFollow on LinkedIn

+ Translate

Treatment of a severely bleeding patient without preexisting coagulopathy with activated recombinant factor VII



Treatment of a severely bleeding patient without preexisting coagulopathy with activated recombinant factor VII



American Journal of Medicine 108(5): 421-423




(PDF same-day service: $19.90)

Accession: 035980690

Download citation: RISBibTeXText

PMID: 10759100

DOI: 10.1016/s0002-9343(99)00398-8



Related references

Successful use of recombinant activated factor VII for trauma-associated hemorrhage in a patient without preexisting coagulopathy. Journal of Trauma 52(2): 400-405, 2002

Treatment of an acquired coagulopathy with recombinant activated factor VII in a damage-control patient. Military Medicine 170(4): 287-290, 2005

Use of recombinant activated factor VII in patients with severe coagulopathy and bleeding. Anesthesiology 98(4): 1025-6; Author Reply 1026-7, 2003

Prolonged recombinant activated factor VII (rFVIIa) treatment for severe bleeding in a factor-IX-deficient patient with an inhibitor. British Journal of Haematology 78(3): 460-463, 1991

Administration of recombinant activated factor VII (NovoSeven) in three cases of uncontrolled bleeding caused by disseminated intravascular coagulopathy. Clinical and Applied Thrombosis/Hemostasis 13(3): 313-317, 2007

Prolonged recombinant activated factor vii rfviia treatment for severe bleeding and surgical hemostasis in a factor ix deficient patient with an inhibitor. Pediatric Research 27(4 PART 2): 149A, 1990

The use of recombinant activated factor VII in the treatment of gastrointestinal bleeding following acetylsalicylic acid therapy in a surgical patient. Srpski Arhiv Za Celokupno Lekarstvo 136 Suppl 3(): 240-245, 2009

Recombinant activated factor VII as an adjunctive therapy for bleeding control in severe trauma patients with coagulopathy: subgroup analysis from two randomized trials. Critical Care 10(6): R178-R178, 2006

Effective treatment of life-threatening bleeding with recombinant activated factor VII in a patient with acute promyelocytic leukaemia. European Journal of Haematology 72(6): 455-456, 2004

Treatment of intra-abdominal bleeding with recombinant activated factor VII in a patient with disseminated intravascular coagulation secondary to septic shock. Blood Coagulation & Fibrinolysis 16(4): 297-299, 2005

Cost-Effectiveness of Recombinant Activated Factor VII as Adjunctive Therapy for Bleeding Control in Severely Injured Trauma Patients in Germany. European Journal of Trauma and Emergency Surgery 33(5): 528-538, 2007

Treatment of severe coagulopathy after gunshot injury to the head using recombinant activated factor VII. Journal of Critical Care 20(2): 176-179, 2005

Recombinant activated factor VII in the treatment of bleeding episodes in patients with inherited and acquired bleeding disorders. Transfusion Medicine Reviews 7(2): 78-83, 1993

Continuous infusion of recombinant activated factor VII for bleeding control after lobectomy in a patient with inherited factor VII deficiency. General Thoracic and Cardiovascular Surgery 64(3): 177-180, 2016